Related Experiment Video
Updated: Dec 24, 2025

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability
Gang Wang1, Lichun Zhao1,2, Qikun Jiang3
1Zhuang Yao Medicine Center of Engineering and Technology, Guang Xi University of Chinese Medicine, Nanning 530200, China.
Abstract:
Various drug transporters are widely expressed throughout the intestine and play important roles in absorbing nutrients and drugs, thus providing high quality targets for the design of prodrugs or nanoparticles to facilitate oral drug delivery. In particular, intestinal carnitine/organic cation transporter 2 (OCTN2) and mono-carboxylate transporter protein 1 (MCT1) possess high transport capacities and complementary distributions. Therefore, we outline recent developments in transporter-targeted oral drug delivery with regard to the OCTN2 and MCT1 proteins in this review. First, basic information of the two transporters is reviewed, including their topological structures, characteristics and functions, expression and key features of their substrates. Furthermore, progress in transporter-targeting prodrugs and nanoparticles to increase oral drug delivery is discussed, including improvements in the oral absorption of anti-inflammatory drugs, antiepileptic drugs and anticancer drugs. Finally, the potential of a dual transporter-targeting strategy is discussed.
Insights
Targeting intestinal transporters like carnitine/organic cation transporter 2 (OCTN2) and mono-carboxylate transporter 1 (MCT1) enhances oral drug delivery. Prodrugs and nanoparticles show promise for improving the absorption of various medications.
Area of Science:
- Pharmacology
- Drug Delivery
- Biochemistry
Background:
- Intestinal drug transporters are crucial for nutrient and drug absorption.
- Carnitine/organic cation transporter 2 (OCTN2) and mono-carboxylate transporter 1 (MCT1) have high transport capacities and complementary distributions.
- These transporters are key targets for enhancing oral drug delivery.
Purpose of the Study:
- To review recent advancements in oral drug delivery strategies targeting OCTN2 and MCT1.
- To discuss the development of prodrugs and nanoparticles for transporter-mediated drug absorption.
- To explore the potential of dual transporter-targeting approaches.
Main Methods:
- Review of existing literature on OCTN2 and MCT1.
- Analysis of prodrug and nanoparticle design for transporter targeting.
- Examination of clinical applications for anti-inflammatory, antiepileptic, and anticancer drugs.
Main Results:
- Detailed information on the structure, function, and substrates of OCTN2 and MCT1.
- Demonstrated improvements in oral absorption of various drugs using transporter-targeted strategies.
- Evidence supporting the efficacy of prodrugs and nanoparticles in enhancing oral bioavailability.
Conclusions:
- OCTN2 and MCT1 are promising targets for improving oral drug delivery.
- Prodrugs and nanoparticles offer effective strategies for transporter-mediated drug absorption.
- Dual targeting of OCTN2 and MCT1 presents a potential future direction for enhanced oral drug delivery.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Delivery: Enteral Route
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Bioavailability Enhancement: Drug Solubility Enhancement
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...

